| Financial Year |
March 31 2023 |
| Monetary Funds |
78,668,223.80 |
| Held-for-trading Financial Assets |
242,468,386.57 |
| Notes Receivable |
200,000.00 |
| Accounts Receivable |
102,872,407.25 |
| Advances to Suppliers |
13,360,700.30 |
| Other Receivables |
10,367,508.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
154,891,714.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,172,375.75 |
| Total Current Assets |
612,482,085.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
316,088,619.20 |
| Investment Properties |
-- |
| Fixed Assetes |
185,632,661.28 |
| Under-construction Projects |
4,806,500.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
69,832,824.89 |
| R&D expenses |
-- |
| Goodwill |
224,142,250.25 |
| Long-Term Deferred and Prepaid Expenses |
3,321,672.06 |
| Deferred Income Tax Assets |
12,307,327.32 |
| Other Non-Current Assets |
19,000.00 |
| Sub-Total of Non-Current Assets |
856,315,202.88 |
| Total Assets |
1,468,797,288.51 |
| Short-Term Loans |
16,479,456.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
39,319,376.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,494,157.06 |
| Taxes Payable |
5,857,164.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
196,978,213.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,302,157.39 |
| Other Current Liabilities |
285,233.86 |
| Sub-Total of Current Liabilities |
279,223,555.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,368,284.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
82,077,517.72 |
| Total Liabilities |
361,301,072.89 |
| Paid-In Capital(Or Share Stock) |
644,000,000.00 |
| Capital Surplus |
119,714,124.84 |
| Surplus Reserve |
84,408,683.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
301,878,319.40 |
| Minority Stockholder's Interest |
-29,972,768.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,137,468,983.71 |
| Owner's Equity（Stockholder's Equity） |
1,107,496,215.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,468,797,288.51 |
